Physician profile
Daniel J Sanchez
NPI 1386194173
$1,322.66
in general payments reported to CMS, 2019-2025
13 companies · $32.34 in 2025
The $32.34 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $742 · 2022: $549 · 2025: $32.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $491.61 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $245.55 | 2021-2022 | |
| Boston Scientific Corporation | $146.11 | 2021-2022 | |
| Amgen INC. | $102.66 | 2021-2022 | |
| Pfizer INC. | $87.35 | 2021 | |
| Vertos Medical, INC. | $81.04 | 2022 | |
| Janssen Pharmaceuticals, INC | $43.42 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $32.34 | 2025 | |
| Glaxosmithkline, LLC. | $24.49 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $21.59 | 2021 | |
| Fidia Pharma USA INC. | $17.28 | 2021 | |
| Grt US Holding, INC. | $15.24 | 2021 | |
| Amarin Pharma, INC. | $13.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.